AI Verdict
LGNZZ has stronger fundamentals based on our AI analysis.
LGVN vs LGNZZ Fundamental Comparison
| Metric | LGVN | LGNZZ |
|---|---|---|
| Revenue | $1.2M | $268.1M |
| Net Income | $-22.7M | $124.5M |
| Net Margin | -1,893.6% | 46.4% |
| ROE | -400.1% | 12.2% |
| ROA | -221.3% | 8.0% |
| Current Ratio | 1.33x | 22.23x |
| Debt/Equity | 0.03x | 0.03x |
| EPS | $-1.29 | $6.13 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LGVN vs LGNZZ: Frequently Asked Questions
Is LGVN or LGNZZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LGNZZ has stronger fundamentals. LGVN is rated STRONG SELL (95% confidence) while LGNZZ is rated BUY (75% confidence). This is not investment advice.
How does LGVN compare to LGNZZ fundamentally?
Longeveron Inc. has ROE of -400.1% vs LIGAND PHARMACEUTICALS INC's 12.2%. Net margins are -1,893.6% vs 46.4% respectively.
Which stock pays higher dividends, LGVN or LGNZZ?
LGVN has a dividend yield of N/A or no dividend while LGNZZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LGVN or LGNZZ for long term?
For long-term investing, consider that LGVN has STRONG SELL rating with 95% confidence, while LGNZZ has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LGVN vs LGNZZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LGVN vs LGNZZ, the AI consensus favors LGNZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.